PRKG2 and type 2 diabetes mellitus: First, western blot and immunofluorescence confirmed the disturbed pathway was ameliorated by cinaciguat, which mainly manifested as high-expression of PKG2 in T2DM-cinacguat group (Figures 4(a)–4(c)).